You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 28, 2024

PEPCID AC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pepcid Ac patents expire, and what generic alternatives are available?

Pepcid Ac is a drug marketed by J And J Consumer Inc and is included in three NDAs.

The generic ingredient in PEPCID AC is famotidine. There are eighteen drug master file entries for this compound. One hundred and thirty-eight suppliers are listed for this compound. Additional details are available on the famotidine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Ac

A generic version of PEPCID AC was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.

  Sign Up

Summary for PEPCID AC
Drug patent expirations by year for PEPCID AC
Recent Clinical Trials for PEPCID AC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterPhase 2/Phase 3
Leidos Life SciencesPhase 2
United States Department of DefensePhase 2

See all PEPCID AC clinical trials

Pharmacology for PEPCID AC

US Patents and Regulatory Information for PEPCID AC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-002 Sep 23, 2003 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PEPCID AC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-001 Sep 24, 1998 ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PEPCID AC

See the table below for patents covering PEPCID AC around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0279682 GELATIN COATED CAPLETS AND PROCESS FOR MAKING SAME ⤷  Sign Up
Greece 920100438 ⤷  Sign Up
Japan S6256871 ⤷  Sign Up
Switzerland 648027 GUANIDINOTHIAZOLVERBINDUNGEN, VERFAHREN ZU DEREN HERSTELLUNG UND ARZNEIMITTELZUBEREITUNGEN. ⤷  Sign Up
Japan H06316536 TASTE-MASKING AND SUSTAINED-RELEASE FILM FOR MEDICINE ⤷  Sign Up
South Africa 8000970 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.